Inflammatory tongue conditions associated with increased risk of oral tongue cancer
1. In this case-control study, those with tongue cancer were found to have ten-fold increases in...
Read MoreDec 6, 2023
1. In this case-control study, those with tongue cancer were found to have ten-fold increases in...
Read MoreDec 1, 2023
Individuals with diabetes who undergo colorectal cancer (CRC) screening, specifically colonoscopy, may be able to mitigate the risk for CRC.
Read MoreNov 28, 2023
An evidence-based guideline to help healthcare professionals give sound advice regarding mental health to people with cancer is sorely needed.
Read MoreNov 28, 2023
1. The median overall survival was 12.1 months in the erdafitinib group and 7.8 months in the...
Read MoreNov 28, 2023
1. Overall pathologic complete response to treatment of triple-negative breast cancer with a...
Read MoreNov 21, 2023
1. Progression-free survival was not reached in the selpercatinib group and was 16.8 months in the...
Read MoreNov 19, 2023
1. For patients with unfavorable nonmetastatic prostate cancer aged above 70 years, PSA levels...
Read MoreNov 14, 2023
Bookmark1. A greater percentage of patients who received concurrent stereotactic radiation therapy...
Read MoreNov 14, 2023
Bookmark1. Progression-free survival was 6.3 months for the amivantamab–chemotherapy group, 8.3...
Read MoreNov 10, 2023
Bookmark1. This phase 3 randomised trial demonstrated that compared with placebo in combination...
Read MoreNov 9, 2023
Bookmark1. Median overall survival increased by 3.2 months in the sacituzumab govitecan group...
Read MoreNov 8, 2023
Bookmark1. In this cross-sectional study, cancer patients enrolled in clinical trials demonstrated...
Read MoreNov 7, 2023
Bookmark1. The progression-free survival was 24.8 months in the selpercatinib group vs 11.2 months in the control group (chemotherapy ± pembrolizumab), with an HR of 0.46. 2. Grade ≥3 adverse events occurred in 70% vs 57%...
Read MoreOct 31, 2023
Bookmark1. Median progression-free survival was 11.4 months in the amivantamab–chemotherapy group...
Read MoreOct 31, 2023
Bookmark1. Median overall survival and progression-free survival were greater in the tebentafusp...
Read MoreOct 31, 2023
Bookmark1. In this retrospective study, the use of deep learning models improved the accuracy of...
Read MoreOct 27, 2023
Bookmark1. The CORE trial showed that a cardio-oncology rehabilitation program demonstrated...
Read MoreOct 24, 2023
Bookmark1 .The progression-free survival in berzosertib with topotecan vs topotecan alone was not...
Read MoreOct 20, 2023
Bookmark1. One-third of patients with a cancer signal were correctly diagnosed to have cancer. 2....
Read MoreOct 18, 2023
Bookmark1. In this cross-sectional study, there was a significant negative relationship between supportive care needs and spiritual well-being and between supportive care needs and psychological resilience in breast cancer...
Read More